39 investors have funded 12 Life Sciences Tech companies head-officed in Oxford, across 62 rounds (Jan 2012 – Jan 2026). They are ranked by how many Oxford companies in this market they have actually backed.
"In Oxford" describes the companies, not the investor: most of the money in any city comes from somewhere else, and the Where the money comes from section below shows exactly where it came from here.
Ranked by companies backed in this market and city, then by round count. "Led" counts rounds recorded with this investor as lead.
| # | Investor | Based in | Stages here | Companies | Rounds | Led | Latest | Portfolio total |
|---|---|---|---|---|---|---|---|---|
| 1 | Oxford Science Enterprises | Oxford, United Kingdom | SeedSeries A | 3 | 5 | 4 | Nov 2025 | 85 |
| 2 | Oxford University Innovation | Oxford, United Kingdom | SeedSeries A | 3 | 3 | — | Nov 2025 | 26 |
| 3 | Bristol-Myers Squibb | New York City, United States | Series DSeries BSeries C | 1 | 4 | 1 | Apr 2021 | 64 |
| 4 | Evotec | Hamburg, Germany | Series ASeries BSeries C | 1 | 4 | 2 | Mar 2021 | 13 |
| 5 | GT Healthcare Capital Partners | Hong Kong, China | Series DSeries BSeries C | 1 | 4 | 1 | Apr 2021 | 12 |
| 6 | Novo Holdings | Hellerup, Denmark | Series DSeries C | 1 | 3 | 1 | Apr 2021 | 286 |
| 7 | o2h ventures | Cambridge, United Kingdom | PESeed | 1 | 3 | 3 | May 2022 | 24 |
| 8 | BlackRock | New York City, United States | Series DSeries C | 1 | 2 | 1 | Apr 2021 | 283 |
| 9 | Borealis Ventures | Hanover, United States | Series A | 1 | 2 | — | Jul 2021 | 39 |
| 10 | Perivoli Innovations | United Kingdom | Series A | 1 | 2 | — | Jul 2021 | 18 |
| 11 | Oxford Investment Consultants | Banbury, United Kingdom | SeedSeries A | 1 | 2 | — | May 2018 | 13 |
| 12 | Y Combinator | Mountain View, United States | Seed | 1 | 1 | — | Jan 2024 | 5,648 |
| 13 | SoftBank Vision Fund | London, United Kingdom | Series D | 1 | 1 | — | Apr 2021 | 325 |
| 14 | Parkwalk | London, United Kingdom | Seed | 1 | 1 | — | Nov 2025 | 135 |
| 15 | Mubadala | Abu Dhabi, United Arab Emirates | Series D | 1 | 1 | — | Apr 2021 | 167 |
| 16 | IP Group | London, United Kingdom | PE | 1 | 1 | 1 | Apr 2017 | 136 |
| 17 | Casdin Capital | New York City, United States | Series D | 1 | 1 | — | Apr 2021 | 136 |
| 18 | Oxford Technology | Henley-on-Thames, United Kingdom | Seed | 1 | 1 | — | Jan 2016 | 70 |
| 19 | ACF Investors | Sheffield, United Kingdom | Seed | 1 | 1 | 1 | May 2022 | 90 |
| 20 | AlphaLab | Pittsburgh, United States | Seed | 1 | 1 | — | Jun 2014 | 100 |
| 21 | AlbionVC | London, United Kingdom | Seed | 1 | 1 | — | Nov 2025 | 78 |
| 22 | Accel-KKR | Menlo Park, United States | PE | 1 | 1 | — | Jun 2013 | 90 |
| 23 | Farallon Capital Management | San Francisco, United States | Series D | 1 | 1 | — | Apr 2021 | 59 |
| 24 | Celgene | Summit, United States | Series B | 1 | 1 | 1 | Jan 2019 | 53 |
| 25 | Marshall Wace | London, United Kingdom | Series D | 1 | 1 | — | Apr 2021 | 54 |
| 26 | Mobeus Equity Partners | London, United Kingdom | Series A | 1 | 1 | 1 | Nov 2018 | 47 |
| 27 | R42 Group | Palo Alto, United States | Seed | 1 | 1 | 1 | May 2022 | 19 |
| 28 | Angel CoFund | Sheffield, United Kingdom | PE | 1 | 1 | 1 | Nov 2019 | 20 |
| 29 | Meltwind Advisory | Cambridge, United States | Seed | 1 | 1 | 1 | May 2022 | 20 |
| 30 | Laurion Capital | New York City, United States | Series D | 1 | 1 | — | Apr 2021 | 17 |
| 31 | Apollo Health Ventures | Cambridge, United States | Seed | 1 | 1 | 1 | Nov 2025 | 14 |
| 32 | Apposite Capital | London, United Kingdom | Series A | 1 | 1 | 1 | Apr 2019 | 10 |
| 33 | Seven Spires | Oxford, United Kingdom | Seed | 1 | 1 | 1 | Jan 2012 | 6 |
| 34 | Pivotal bioVenture Partners China | Shanghai, China | Series D | 1 | 1 | — | Apr 2021 | 8 |
| 35 | YZR Capital | Seed | 1 | 1 | — | Nov 2025 | 9 | |
| 36 | RT Ventures | Glasgow, United Kingdom | Series A | 1 | 1 | — | May 2018 | 5 |
| 37 | Bija Ventures | Seed | 1 | 1 | — | Jan 2026 | 4 | |
| 38 | Busolantix Investment | PE | 1 | 1 | — | Apr 2017 | 1 | |
| 39 | American Chemical Society | Washington, DC, United States | Seed | 1 | 1 | 1 | May 2012 | 1 |
Head office of the investors on this page.
Rounds by stage — where in a company's life this money arrives.
Total disclosed size of each round, not one investor's share.
How active this market has been.
Life Sciences Tech companies head-officed in Oxford that took money from these investors.
| Company | Backers | Rounds | Disclosed | Latest round |
|---|---|---|---|---|
| Exscientia exscientia.com |
13 | 25 | $3.3B | Series D Apr 2021 |
| Orbit Discovery orbitdiscovery.com |
7 | 12 | $71.6M | Series A Jul 2021 |
| Oxford Drug Design oxforddrugdesign.com |
7 | 9 | $22.2M | Seed May 2022 |
| Scripta Therapeutics scriptatherapeutics.com |
6 | 6 | $71.5M | Seed Nov 2025 |
| colwiz colwiz.com |
3 | 3 | $2.3M | Seed May 2012 |
| Mirada Medical mirada-medical.com |
1 | 1 | $7.8M | Series A Apr 2019 |
| Ground Truth Labs groundtruthlabs.com |
1 | 1 | $4.3M | Series A Jun 2023 |
| Kudos growkudos.com |
1 | 1 | $2.5M | Series A Nov 2018 |
| Evolvere BioSciences evolverebiosciences.com |
1 | 1 | $500K | Seed Jan 2024 |
| ResearchWe researchwe.com |
1 | 1 | $25K | Seed Jun 2014 |
| Coding Bio coding.bio |
1 | 1 | — | Seed Jan 2026 |
| Zinc Ahead zinc-ahead.com |
1 | 1 | — | PE Jun 2013 |
| Date | Investor | Company | Stage | Round size |
|---|---|---|---|---|
| Jan 2026 | Bija Ventures | Coding Bio | Seed | — |
| Nov 2025 | Oxford University Innovation | Scripta Therapeutics | Seed | $11.9M |
| Nov 2025 | Apollo Health VenturesLED | Scripta Therapeutics | Seed | $11.9M |
| Nov 2025 | YZR Capital | Scripta Therapeutics | Seed | $11.9M |
| Nov 2025 | Parkwalk | Scripta Therapeutics | Seed | $11.9M |
| Nov 2025 | AlbionVC | Scripta Therapeutics | Seed | $11.9M |
| Nov 2025 | Oxford Science EnterprisesLED | Scripta Therapeutics | Seed | $11.9M |
| Jan 2024 | Y Combinator | Evolvere BioSciences | Seed | $500K |
| Jun 2023 | Oxford Science EnterprisesLED | Ground Truth Labs | Series A | $4.3M |
| May 2022 | R42 GroupLED | Oxford Drug Design | Seed | $2.7M |
| May 2022 | ACF InvestorsLED | Oxford Drug Design | Seed | $2.7M |
| May 2022 | o2h venturesLED | Oxford Drug Design | Seed | $2.7M |
| May 2022 | Meltwind AdvisoryLED | Oxford Drug Design | Seed | $2.7M |
| Jul 2021 | Perivoli Innovations | Orbit Discovery | Series A | $7.6M |
| Jul 2021 | Borealis Ventures | Orbit Discovery | Series A | $7.6M |
| Jul 2021 | Oxford Science EnterprisesLED | Orbit Discovery | Series A | $7.6M |
| Apr 2021 | Bristol-Myers Squibb | Exscientia | Series D | $225M |
| Apr 2021 | Marshall Wace | Exscientia | Series D | $225M |
| Apr 2021 | GT Healthcare Capital Partners | Exscientia | Series D | $225M |
| Apr 2021 | Novo Holdings | Exscientia | Series D | $225M |
Life Sciences Tech investors in other cities
Other markets in Oxford